An AI agent selected a gene therapy and injected it into a live mouse’s brain. The experiment was conducted by a biotech startup. It offers a startling glimpse of how AI could change research labs.
The agent chose the treatment without human direction. It then carried out the injection successfully. The mouse survived the procedure.
This marks a step beyond AI that only analyzes data. Here, the system acted in the physical world. It made decisions and executed them.
Gene therapy research typically requires expert scientists. Selecting a treatment and performing surgery are complex tasks. The AI handled both in one workflow.
The startup has not released full details of the experiment. It is unclear how much human oversight was involved. The results have not been peer-reviewed.
Safety remains a major question. Letting AI perform surgery on living animals raises ethical concerns. Researchers will need to define clear limits.
The work suggests AI agents could soon assist in labs. They might handle repetitive or precise tasks. Human scientists would still set goals and check results.
Experts say the technology is early-stage. Much more testing is needed before similar systems are used widely. The mouse experiment is a proof of concept, not a routine tool.
